reviewThe LancetNov 1, 2006Closed access

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

DJDaniel J. Drucker MAMichael A. Nauck

Lunenfeld-Tanenbaum Research Institute · University of Toronto · +2 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

3,864

total citations

FWCI: 77.29
Percentile: 100%
References: 121

Citations per year

Authors

2

DJ
Daniel J. DruckerCorresponding
Lunenfeld-Tanenbaum Research Institute, University of Toronto, Mount Sinai Hospital
MA
Michael A. Nauck
Diabeteszentrum Bad Lauterberg

Topics & keywords

Topics

Keywords

Vildagliptin
Incretin
Exenatide
Liraglutide
Sitagliptin
Medicine
Type 2 diabetes
Internal medicine

No related works found for this paper.

Funding